AVITA Medical Inc. (RCEL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AVITA Medical Inc.

    NASDAQ: RCEL · Real-Time Price · USD
    4.26
    -0.03 (-0.70%)
    At close: Sep 05, 2025, 3:59 PM
    4.19
    -1.64%
    After-hours: Sep 05, 2025, 07:44 PM EDT

    AVITA Medical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 64.25M 50.14M 50.56M 33.02M
    Cost of Revenue
    		 9.09M 7.78M 8.87M 6.1M
    Gross Profit
    		 55.16M 42.36M 41.69M 26.92M
    Operating Income
    		 -56.59M -42.66M -40.4M -25.12M
    Interest Income
    		 n/a n/a 23.5K n/a
    Pretax Income
    		 -61.79M -35.31M -39.12M -25.1M
    Net Income
    		 -61.84M -35.38M -39.17M -25.14M
    Selling & General & Admin
    		 91.39M 65.63M 66.46M 37.92M
    Research & Development
    		 20.36M 20.82M 20.35M 15.67M
    Other Expenses
    		 n/a -1.43M n/a -1.55M
    Operating Expenses
    		 111.75M 85.02M 80.78M 52.04M
    Interest Expense
    		 5.36M 1.14M n/a n/a
    Selling & Marketing Expenses
    		 58.2M 37.29M 32.19M 16.27M
    Cost & Expenses
    		 120.84M 92.8M 89.65M 58.14M
    Income Tax Expense
    		 54K 66K 52.88K 42K
    Shares Outstanding (Basic)
    		 25.88M 25.33M 25M 24.36M
    Shares Outstanding (Diluted)
    		 25.88M 25.33M 25M 24.36M
    EPS (Basic)
    		 -2.39 -1.4 -1.57 -1.03
    EPS (Diluted)
    		 -2.39 -1.4 -1.57 -1.03
    EBITDA
    		 -55.34M -32.45M -39.57M -24.4M
    EBIT
    		 -56.43M -34.17M n/a -25.08M
    Depreciation & Amortization
    		 1.13M 632K 1.46M 673K

    Add to Watchlist